Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third party review pilot staggers forward:

This article was originally published in Clinica

Executive Summary

The Office of Device Evaluation's two-year voluntary programme of third party review for low and moderate risk products is to be expanded in 1998, despite having attracted only five submissions to date. Guidance for 16 of the 30 classes of device included in the pilot is now available, and the remaining device categories will be covered by the end of May. In 1998, said Susan Alpert, head of the ODE, as many as 30 more categories of device could be added to the pilot.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT084564

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel